×

Equipment and Services Health Care Equipment and Supplies

  • May 12- A global cyber attack on Friday affected British hospitals, government agencies and companies in 99 countries, with Russia, Ukraine and Taiwan the top targets, Security software maker Avast said. Hacking tools widely believed by researchers to have been developed by the U.S. National Security Agency that were leaked online last month appear to have been...

  • LONDON/ MADRID, May 12- A global cyberattack leveraging hacking tools widely believed by security researchers to have been developed by the U.S. National Security Agency disrupted Britain's health system and infected computers in dozens of other countries on Friday. Telecommunications company Telefonica was among many targets in Spain, though it said the...

  • WASHINGTON, May 12- Microsoft said on Friday its engineers had added detection and protection against a ransomware attack that had disrupted hospitals in England and infected computers in dozens of other countries around the world. "Today our engineers added detection and protection against new malicious software known as Ransom: Win32.WannaCrypt," a...

  • LONDON/ MADRID, May 12- A huge cyber attack leveraging hacking tools widely believed to have been developed by the U.S. National Security Agency brought disruption to Britain's health system on Friday and infected dozens of other countries around the world, security researchers said. Hospitals and doctors' surgeries in parts of England were forced to turn away...

  • LONDON, May 12- Malicious software called' ransomware' has forced British hospitals to turn away patients and affected Spanish companies such as Telefonica as part of a global outbreak that has affected tens of thousands of computers. What is WannaCry- also known as WanaCrypt0r 2.0, WannaCry and WCry? British based cyber researcher Chris Doman of AlienVault...

  • LONDON/ MADRID, May 12- A huge cyberattack brought disruption to Britain's health system on Friday and infected many Spanish companies with malicious software, and security researchers said a dozen other countries may be affected. "We are experiencing a major IT disruption and there are delays at all of our hospitals," said the Barts Health group, which manages...

  • SANTIAGO, May 10- Pharmacies in Chile's capital Santiago will start selling cannabis-based medicines this week, the first time such treatments have been offered by drug stores in Latin America, the companies behind the launch said on Wednesday. Chile legalized the use of medical marijuana in 2015 and is among a number of Latin American countries gradually...

  • *AstraZeneca sets durvalumab price at $15,000/ month. Leerink analyst Seamus Fernandez sees durvalumab capturing a modest 10 percent of the estimated $2.3 billion global bladder cancer market, while AstraZeneca in 2014 put the drug's peak sales in all cancers at $6.5 billion, including combination use. The U.S. Food and Drug Administration said late on Monday...

  • *AstraZeneca sets durvalumab price at $15,000/ month. May 1- U.S. regulators have approved AstraZeneca's key immunotherapy drug durvalumab as a treatment for bladder cancer, marking the first commercial green light for a product the company hopes will go on to sell billions of dollars. The U.S. Food and Drug Administration said on Monday it granted accelerated...

  • May 1- The U.S. Food and Drug Administration on Monday granted accelerated approval to AstraZeneca Plc's immuno-oncology drug to treat a type of bladder cancer in patients whose disease progressed despite chemotherapy. The FDA also approved a complementary diagnostic from Roche Holding AG to assess whether the PD-L1 protein is expressed in urothelial...

  • WASHINGTON, April 25- Four years ago, two analysts who liked to swap notes on numbers they thought looked odd took a fateful step and tipped off U.S. regulators about a company that one of them had watched for months. Orthofix International NV caught one of the analysts' attention in 2012. The Texas- based medical device maker kept hitting ambitious earnings targets...

  • WASHINGTON, April 25- Four years ago, two analysts who liked to swap notes on numbers they thought looked odd took a fateful step and tipped off U.S. regulators about a company that one of them had watched for months. Orthofix International NV caught one of the analysts' attention in 2012. The Texas- based medical device maker kept hitting ambitious earnings targets...

  • April 18- U.S. drug distributor Cardinal Health Inc agreed to buy medical device maker Medtronic Plc's medical supplies units for $6.1 billion and said it expected full-year adjusted earnings at the lower end of its forecast. Cardinal Health, which had forecast adjusted profit in the range of $5.35- $5.50 per share, blamed generic price deflation for the...

  • April 18- U.S. drug distributor Cardinal Health Inc said on Tuesday it would buy medical device maker Medtronic Plc's medical supplies businesses for $6.1 billion in cash. Cardinal Health is acquiring the patient care, deep vein thrombosis and nutritional insufficiency units from Medtronic. Cardinal Health said it would finance the acquisition with cash...

  • The FDA, which said the company failed to disclose at least one death associated with one of the devices, said an inspection of the company's facility in Sylmar, California, raised questions about the safety of several implantable defibrillators and its Merlinzhome monitor, which allows doctors to care remotely for patients with cardiac devices.

  • April 12- Medical device maker Hologic Inc has been hit with a lawsuit alleging its product for treating heavy menstrual bleeding infringes patented technology developed by start-up Minerva Surgical Inc, court papers show. The product was launched in Europe, Canada and Australia in 2016.. Its backers include the venture capital firms New Enterprise...

  • April 9- Shares of Glaukos Corp could fall 30 percent in the next year, as years of success by the medical device maker has attracted competition from larger companies that threaten its market share, according to the April 10 edition of Barron's. Glaukos shares have risen 150 percent to around $50 since June 2015, trading at 300 times expected earnings and 10 times...

  • Protesters demonstrate against President Donald Trump and his plans to end Obamacare outside the White House in Washington, March 23, 2017.

    "Huge shocks from the political system are always a distraction," athenahealth's Jonathan Bush told CNBC.

  • March 30- Boston Scientific Corp on Thursday agreed to buy Swiss medical device maker Symetis SA for $435 million, looking to bolster its presence in Europe after recalling a range of heart valves in the region. The company's Acurate systems will broaden Boston Scientific's TAVR range to include additional designs and delivery methods that cover more...

  • March 30- Boston Scientific Corp said on Thursday it would buy Swiss medical device maker Symetis SA for $435 million, a deal that will help the U.S. company expand in the European market. Boston Scientific in February recalled its Lotus valve devices from Europe and other regions following reports of a faulty locking mechanism. The acquisition would allow...